Rising Adoption of Minimally Invasive Surgeries is Expected to Drive the Growth of the Specimen Retrieval Bag Market

 
Specimen Retrieval Bag Market

Specimen retrieval bags are sterile pouches used to remove specimens such as tissue or fluid from the body during minimally invasive surgery without contaminating the operating room or compromising sterility. They are typically made from medical-grade plastic and have drawstrings at the top to close tightly after use. Some key uses of specimen retrieval bags include laparoscopic appendectomy, laparoscopic cholecystectomy (gallbladder removal), laparoscopic hysterectomy, and removal of lesions or tumors.


The global specimen retrieval bag market is primarily driven by the increasing preference for minimally invasive surgeries over traditional open surgeries. Minimally invasive procedures are associated with reduced postoperative pain, shorter hospital stay, and faster recovery times compared to open surgeries. They cause minimal damage to surrounding tissues and reduce surgical scarring. As such, they are the preferred option for various general surgical procedures. The advancement of laparoscopic techniques has also boosted the adoption of specimen retrieval bags.

The global specimen retrieval bag market is estimated to be valued at US$ 308.36 Mn in 2023 and is expected to exhibit a CAGR of 24% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The global specimen retrieval bag market is primarily driven by increasing adoption of minimally invasive surgeries and technological advancements in laparoscopic techniques. According to the American Society for Metabolic and Bariatric Surgery, in the U.S., the number of annual bariatric and metabolic surgeries has increased from 158,000 procedures in 2011 to 252,000 procedures in 2018. A majority of these procedures were performed using minimally invasive techniques. The preference for minimally invasive approaches stems from favorable outcomes compared to traditional open surgeries such as less postoperative pain, fewer surgical scars, faster recovery, and shorter hospital stay.

Another key driver is the continuous development of advanced energy devices and articulating instruments used in minimally invasive procedures. Newer generation devices offer improved visualization, tool maneuverability, tissue effect, and procedural versatility. They enable complex abdominal surgeries to be performed using small incisions compared to open techniques. As a result, the usage of specimen retrieval bags has increased in line with rising adoption of minimally invasive modalities.


Segment Analysis
There are four key segments in the Specimen Retrieval Bag Market. The sealing segment dominates with around 35% market share as sealing bags ensure no spills or leaks during transportation of specimens. These bags have reliable sealing technology like zip-lock features or reinforced adhesive strips to prevent accidental openings during handling.

PEST Analysis
Political: The market is positively impacted by regulations supporting use of retrieval bags in surgical procedures. However, varying laws across countries can restrain market growth to some extent.
Economic: Rising healthcare spending and growing economy have increased budget for surgical consumables like retrieval bags. Higher disposable incomes also support market expansion.
Social: Growing geriatric population undergoing various surgeries and increase in number of surgeries performed are key social factors driving the need for specimen retrieval bags.
Technological: Automation in bag sealing technologies has enhanced bag quality. Advances in material sciences are allowing development of improved polymer mixes for greater strength and barrier properties in bags.

Key Takeaways
The Global Specimen Retrieval Bag Market is expected to witness high growth over the forecast period of 2023 to 2030. The global specimen retrieval bag market is estimated to be valued at US$ 308.36 Mn in 2023 and is expected to exhibit a CAGR of 24% over the forecast period 2023 to 2030.

The North American region currently dominates due to large number of surgical procedures carried out and presence of major players. This is attributed to factors such as increasing healthcare spending, rising prevalence of chronic diseases, and technological advancements in the healthcare sector of the countries in the region.

Key players: The key players operating in the specimen retrieval bag market are BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc., and Medical Marijuana Inc. BOL Pharma leads the market with innovative sealing mechanisms while Medreleaf has a wide product portfolio.

Comments

Post a Comment

Popular posts from this blog

Precast Concrete Market Is Estimated To Witness High Growth Owing To Increasing Demand for Sustainable Construction Practices

Image
Precast Concrete Market Market Overview: The Precast Concrete Market is witnessing significant growth due to the increasing demand for sustainable construction practices. Precast concrete products are prefabricated in controlled factory conditions, offering several advantages such as improved quality control, reduced construction time, and increased durability. These products are widely used in residential, commercial, and infrastructure projects due to their ability to enhance construction efficiency and productivity. With the growing need for energy-efficient and environmentally friendly buildings, the demand for precast concrete products is expected to rise. Market Key Trends: One key trend in the Precast Concrete Market is the adoption of advanced technology in manufacturing processes. The use of computer-aided design (CAD) and building information modeling (BIM) is enabling manufacturers to produce complex and customized precast concrete products with high precision. Additional
Read more

Relapsed Or Refractory Diffuse Large B Cell Lymphoma Market Growth driven by increased adoption of targeted therapies

Image
Relapsed Or Refractory Diffuse Large B Cell Lymphoma Market Market Overview: Relapsed Or Refractory Diffuse Large B Cell Lymphoma (R/R DLBCL) is an aggressive fast-growing type of non-Hodgkin's lymphoma (NHL) cancer that generally affects immune system cells called B cells. DLBCL can occur at any age but is most common in older adults. Novel targeted therapies like chimeric antigen receptor (CAR) T-cell therapies, bispecific antibodies and antibody-drug conjugates are revolutionizing the treatment of R/R DLBCL. These advanced therapies are offering new hope to patients by increasing survival rates. Market key trends: One of the key trends in the R/R DLBCL market is the increasing adoption of CAR T-cell therapies. CAR T-cell therapy is an innovative new approach to treating R/R DLBCL through the use of genetically engineered T-cells. Drugs like Kymriah and Yescarta have proven highly effective in treating certain patients with relapsed or refractory forms of large B-cell lymphoma.
Read more

The global Biopharmaceuticals Market connected with therapeutic biologics

Image
Biopharmaceuticals Market Market Overview: The biopharmaceuticals market comprises medicines produced using biotechnology methods like genetic engineering and includes vaccines, blood components, recombinant therapeutic proteins/antibodies, and monoclonal antibodies. Biopharmaceuticals are often used for treating serious medical conditions like cancer, autoimmune diseases, and other chronic disorders. These drugs provide targeted treatment options and have lesser side effects than traditional small-molecule drugs. The market is witnessing high demand due to increasing prevalence of chronic diseases and growing geriatric population globally. Market key trends: One of the key trends gaining traction in The Biopharmaceuticals Market Demand is the increasing adoption of biosimilars. Biosimilars are quasi-generic versions of original biologics and provide more affordable treatment options when the patents of biologics expire. Regulatory agencies in various regions are also approving bios
Read more